Schedule 13G ownership disclosure

AVEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 053588109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,352,120
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-14-002383
Form type
SC 13G/A
Filer
AVEO PHARMACEUTICALS, INC.
CIK
CIK 1325879
Filed
Jul 10, 2014
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub